Shanghai INT Medical Instruments Co., Ltd. (INT Medical) disclosed in its Monthly Return for Equity Issuer that, on 3 June 2026, 71.79 million domestic shares were converted into an equal number of H shares.

Following the conversion, the company’s entire issued share capital now consists of 211.20 million ordinary H shares with a par value of RMB1.00 each, all listed on the Hong Kong Stock Exchange. Compared with the end of May, the H-share count increased by 51.53%, while the domestic-share class was fully cancelled.

INT Medical confirmed that the public float meets the Main Board’s 25% minimum requirement. No share options, warrants, convertibles, treasury shares or other equity instruments were outstanding or transacted during the month.

The filing was signed by Chairman and Executive Director Liang Dongke on 2 July 2026.